Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis
NCT ID: NCT02640391
Last Updated: 2019-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
127 participants
OBSERVATIONAL
2016-01-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognostic Value of Confocal Endomicroscopy in Ulcerative Colitis: the CONF-UC Study
NCT06624579
Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis
NCT07111572
Metagenomic Analysis of Gut Microbiome in Korean Patients With Ulcerative Colitis
NCT01010815
Remote Monitoring of IBD
NCT05886322
Ulcerative Colitis Endoscopic Index of Severity and Fecal Calprotectin to Predict the Reaction to Corticosteroids of Acute Severe Ulcerative Colitis
NCT02922374
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Quiescent UC
Patients with quiscent UC who will undergo colonoscopy for surveillance or mucosal healing check up
colonoscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
colonoscopy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with ulcerative colitis who are in remission (Mayo score \<3)
* Patients with ulcerative colitis who will undergo colonoscopy for surveillance or mucosal healing check-up
Exclusion Criteria
* Patients who have a history of colectomy
* Patients who have instinal stricture or perforation
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kyungpook National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eun Soo Kim, MD, PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eun Soo Kim, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Keimyung University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Keimyung University Dongsan Medical Center
Daegu, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KMU-151215
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.